Solve Therapeutics has completed a $120 million unlabelled round as it advances a pair of antibody-drug conjugates (ADCs) for cancer that use its proprietary linker technology. San Diego-based Solve ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Since the launch of the Crossword in 1942, The Times has captivated solvers by providing engaging word and logic games. In 2014, we introduced the Mini Crossword — followed by Spelling Bee, Letter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results